The results are in...Obesity rates for U.S. adults continue to drop—potentially from the rise of GLP-1 drugs like Ozempic. We asked if you think this is something that grocers need to pay more attention to. Some 61% of you said yes, it’s a shift with impact. Have another thought? Weigh in on the comments here
See the Results